Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 257

1.

Genetic and pharmacological evidence of a role for GABA(B) receptors in the modulation of anxiety- and antidepressant-like behavior.

Mombereau C, Kaupmann K, Froestl W, Sansig G, van der Putten H, Cryan JF.

Neuropsychopharmacology. 2004 Jun;29(6):1050-62.

2.

GABAB receptor antagonist-mediated antidepressant-like behavior is serotonin-dependent.

Slattery DA, Desrayaud S, Cryan JF.

J Pharmacol Exp Ther. 2005 Jan;312(1):290-6. Epub 2004 Aug 27.

3.

Effects of GABAB receptor ligands in animal tests of depression and anxiety.

Frankowska M, Filip M, Przegaliński E.

Pharmacol Rep. 2007 Nov-Dec;59(6):645-55.

4.

Genetic inactivation of the NMDA receptor NR2A subunit has anxiolytic- and antidepressant-like effects in mice.

Boyce-Rustay JM, Holmes A.

Neuropsychopharmacology. 2006 Nov;31(11):2405-14. Epub 2006 Feb 8.

5.

Behavioral characterization of the novel GABAB receptor-positive modulator GS39783 (N,N'-dicyclopentyl-2-methylsulfanyl-5-nitro-pyrimidine-4,6-diamine): anxiolytic-like activity without side effects associated with baclofen or benzodiazepines.

Cryan JF, Kelly PH, Chaperon F, Gentsch C, Mombereau C, Lingenhoehl K, Froestl W, Bettler B, Kaupmann K, Spooren WP.

J Pharmacol Exp Ther. 2004 Sep;310(3):952-63. Epub 2004 Apr 27.

6.

Altered anxiety and depression-related behaviour in mice lacking GABAB(2) receptor subunits.

Mombereau C, Kaupmann K, Gassmann M, Bettler B, van der Putten H, Cryan JF.

Neuroreport. 2005 Feb 28;16(3):307-10.

PMID:
15706241
7.

Behavioral evaluation of mice deficient in GABA(B(1)) receptor isoforms in tests of unconditioned anxiety.

Jacobson LH, Bettler B, Kaupmann K, Cryan JF.

Psychopharmacology (Berl). 2007 Mar;190(4):541-53. Epub 2006 Dec 15.

PMID:
17171558
8.

Behavioral profile of P2X7 receptor knockout mice in animal models of depression and anxiety: relevance for neuropsychiatric disorders.

Basso AM, Bratcher NA, Harris RR, Jarvis MF, Decker MW, Rueter LE.

Behav Brain Res. 2009 Mar 2;198(1):83-90. doi: 10.1016/j.bbr.2008.10.018. Epub 2008 Oct 18.

PMID:
18996151
9.

Evaluation of the anxiolytic-like profile of the GABAB receptor positive modulator CGP7930 in rodents.

Jacobson LH, Cryan JF.

Neuropharmacology. 2008 Apr;54(5):854-62. doi: 10.1016/j.neuropharm.2008.01.004. Epub 2008 Jan 13.

PMID:
18328507
10.

Embryonic GABA(B) receptor blockade alters cell migration, adult hypothalamic structure, and anxiety- and depression-like behaviors sex specifically in mice.

Stratton MS, Staros M, Budefeld T, Searcy BT, Nash C, Eitel C, Carbone D, Handa RJ, Majdic G, Tobet SA.

PLoS One. 2014 Aug 27;9(8):e106015. doi: 10.1371/journal.pone.0106015. eCollection 2014.

11.

Effects of GABAB receptor ligands in rodent tests of anxiety-like behavior.

Partyka A, Kłodzińska A, Szewczyk B, Wierońska JM, Chojnacka-Wójcik E, Librowski T, Filipek B, Nowak G, Pilc A.

Pharmacol Rep. 2007 Nov-Dec;59(6):757-62.

12.

Somatostatin receptor subtype 4 activation is involved in anxiety and depression-like behavior in mouse models.

Scheich B, Gaszner B, Kormos V, László K, Ádori C, Borbély É, Hajna Z, Tékus V, Bölcskei K, Ábrahám I, Pintér E, Szolcsányi J, Helyes Z.

Neuropharmacology. 2016 Feb;101:204-15. doi: 10.1016/j.neuropharm.2015.09.021. Epub 2015 Sep 18.

PMID:
26387439
13.

Antidepressant and anti-anxiety like effects of 4i (N-(3-chloro-2-methylphenyl) quinoxalin-2-carboxamide), a novel 5-HT3 receptor antagonist in acute and chronic neurobehavioral rodent models.

Gupta D, Radhakrishnan M, Thangaraj D, Kurhe Y.

Eur J Pharmacol. 2014 Jul 15;735:59-67. doi: 10.1016/j.ejphar.2014.04.008. Epub 2014 Apr 18.

PMID:
24747753
14.

Activation but not blockade of GABAB receptors during early-life alters anxiety in adulthood in BALB/c mice.

Sweeney FF, O'Leary OF, Cryan JF.

Neuropharmacology. 2014 Jun;81:303-10. doi: 10.1016/j.neuropharm.2013.08.039. Epub 2013 Sep 17.

PMID:
24050962
15.

Antidepressant and anxiolytic-like effects in mice lacking the group III metabotropic glutamate receptor mGluR7.

Cryan JF, Kelly PH, Neijt HC, Sansig G, Flor PJ, van Der Putten H.

Eur J Neurosci. 2003 Jun;17(11):2409-17.

PMID:
12814372
16.

Blockade of the GABA(B) receptor increases neurogenesis in the ventral but not dorsal adult hippocampus: relevance to antidepressant action.

Felice D, O'Leary OF, Pizzo RC, Cryan JF.

Neuropharmacology. 2012 Dec;63(8):1380-8. doi: 10.1016/j.neuropharm.2012.06.066. Epub 2012 Aug 1.

PMID:
22884610
17.

Effects of chronic fluoxetine in animal models of anxiety and depression.

Dulawa SC, Holick KA, Gundersen B, Hen R.

Neuropsychopharmacology. 2004 Jul;29(7):1321-30.

18.

GABAB receptor ligands do not modify conditioned fear responses in BALB/c mice.

Sweeney FF, O'Leary OF, Cryan JF.

Behav Brain Res. 2013 Nov 1;256:151-6. doi: 10.1016/j.bbr.2013.07.035. Epub 2013 Aug 8.

PMID:
23933467
19.

Biphasic effects of cannabinoids in anxiety responses: CB1 and GABA(B) receptors in the balance of GABAergic and glutamatergic neurotransmission.

Rey AA, Purrio M, Viveros MP, Lutz B.

Neuropsychopharmacology. 2012 Nov;37(12):2624-34. doi: 10.1038/npp.2012.123. Epub 2012 Aug 1.

20.

Ondansetron, a 5HT3 receptor antagonist reverses depression and anxiety-like behavior in streptozotocin-induced diabetic mice: possible implication of serotonergic system.

Gupta D, Radhakrishnan M, Kurhe Y.

Eur J Pharmacol. 2014 Dec 5;744:59-66. doi: 10.1016/j.ejphar.2014.09.041. Epub 2014 Oct 2.

PMID:
25284215

Supplemental Content

Support Center